Center for Oncology Research & Treatment, PA

Dallas, Texas 75230

0 studies enrolling now · 7 studies all time

What they study most

Colonic Neoplasms, Colorectal Neoplasms, High Risk Stage III Melanoma, Melanoma, Multiple Myeloma, Prostate Cancer, Rectal Neoplasms

Studies at this site

• Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer. — Completed
• Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma — Completed
• Study of Immunotherapy to Treat Advanced Prostate Cancer — Completed
• A Companion Study for Patients Enrolled in Prior/Parent Ipilimumab Studies — Completed
• A Multiple Myeloma Trial in Patients With Bone Metastases — Completed
• Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma — Completed
• Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients — Stopped early